Neurocrine Biosciences CHRO Julie Cooke Vests PRSUs with Tax Withholding
NEUROCRINE BIOSCIENCES INC
Subscribe to track NBIX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 4 Filed for Neurocrine Biosciences Inc ($NBIX) Insider: Julie Cooke (Chief Human Resources Officer) Transaction Date: September 11, 2026 Details: ā¢ Acquired: 3,587 shares via PRSU performance achievement ($0.00) ā¢ Disposed (Tax Withholding): 1,936 shares @ $156.22 ($302,441.92) ā¢ Post-Transaction Holdings: 24,025 shares Significance: Low (Routine PRSU vesting and tax withholding)
Comprehensive Analysis
Transaction Summary
On September 11, 2026, Julie Cooke, Chief Human Resources Officer of Neurocrine Biosciences Inc ($NBIX), acquired 3,587 shares of common stock following the certification of performance metrics for previously granted performance restricted stock units (PRSUs). Concurrently, 1,936 shares were withheld by the company at a market price of $156.22 per share to satisfy statutory tax withholding obligations, totaling approximately $302,441.92. Following these transactions, Cooke beneficially owns 24,025 shares of common stock (including 21,985 shares held indirectly via the Cooke Family Trust).
Market & Strategic Impact
- Nature of Trade: These transactions reflect routine equity compensation settlement and tax withholding rather than discretionary open-market buying or selling.
- Significance: Low. The disposition was strictly a company-withheld tax settlement with no shares sold into the open market.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.